Add 2 More Reports For 20% off

Report Overview

The global cardiovascular information system market was valued at USD 1.31 billion in 2023. It is expected to grow at a CAGR of 9.2% during the forecast period of 2024-2032 and attain a market value of USD 2.89 billion by 2032. The market growth is driven by the rising prevalence of cardiovascular diseases and the growing demand for point-of-care testing. Patents are focused on advanced technologies such as CVIS and cardiology PACS among cardiovascular information systems.

Patent Landscape Report Coverage

The Global Cardiovascular Information System Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for cardiovascular information systems include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with cardiovascular information systems. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within Cardiovascular Information System technologies.

Key Inclusions:

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for cardiovascular information system technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with the cardiovascular information system.

Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for cardiovascular information systems and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for cardiovascular information systems and their relative value in the IP are covered in the final report. 

Cardiovascular Information System Patent Outlook

  • The need for sophisticated cardiovascular information systems is being driven by the rising prevalence of cardiovascular diseases (CVDs) across the globe. These systems address the increasing healthcare burden of CVDs by improving diagnosis, treatment planning, and patient management.
  • Cardiovascular information systems (CIS) are becoming more capable thanks to technological advancements like artificial intelligence and machine learning. These developments increase the precision of diagnosis, data analysis, and patient monitoring, increasing the appeal of these systems to medical professionals. As a result, the patent applications are also witnessing a surge.
  • The market is expanding due to the growing awareness of heart health issues and the advantages of early detection and preventive care. The need for sophisticated information systems is growing as people and healthcare providers look for more all-encompassing solutions for cardiovascular health.

What is a Cardiovascular Information System?

A cardiovascular information system (CVIS) is a specialized software platform used to organize and evaluate cardiovascular data. It combines data from patient records and different diagnostic tools to improve diagnostic accuracy, expedite workflows, and assist in clinical decision-making. For the best possible care and management of cardiovascular conditions, CVISs are essential.

The components of the cardiovascular information system include software and services. The software within a cardiovascular information system (CVIS) is responsible for managing and integrating cardiovascular data from multiple sources, including electronic health records and imaging devices. It helps medical professionals to diagnose and treat patients with confidence by streamlining workflows and analyzing patient data. To improve clinical effectiveness and patient care, the software frequently has features like data visualization, reporting tools, and decision support.

Cardiovascular Information System Industry Growth Drivers

Advancements in Technology is Expected to Boost the Patent Industry Growth

Cardiovascular information systems are being greatly improved by ongoing technological advancements like artificial intelligence (AI) and machine learning. For instance, Philips unveiled its newest CVIS called the IntelliSpace Cardiovascular 5.0. It uses cutting-edge AI algorithms to enhance workflow effectiveness and image analysis. This development, which improves operational efficiency and diagnostic precision, is an example of how technological advancements propel the evolution and adoption of cardiovascular information systems. Patents covering these technologies are crucial for companies and thus impact the cardiovascular information system patent landscape.

Currently, there is an increase in patent activity which focuses on enhancing the performance of cardiovascular information systems. There were 4,405 patents granted in 2022 and by 2023, the number increased to 4,668 patents.

Rising Cardiovascular Diseases is Expected to Propel Cardiovascular Information System Patent Industry

The need for sophisticated diagnostic and management systems that can handle complex data and deliver precise insights is increased by the rising number of cases of cardiovascular diseases. To improve patient outcomes and manage the rising demand for healthcare, advanced systems assist healthcare providers in effectively tracking, analyzing, and treating cardiovascular conditions.

Cardiovascular Information System Patent Segmentation

The report will cover the following sections in detail:

Analysis by System Type

  • CVIS 
  • Cardiology PACS

Analysis by Component

  • Software
  • Services

Analysis by Mode of Operation

  • Web-Based 
  • Cloud Based 
  • On-Site 

Cardiovascular Information System Patent Segmentation Analysis

The breakup based on system type includes CVIS and cardiology PACS. Cardiology PACS (Picture Archiving and Communication System) is a specialized imaging system used to store, retrieve, and manage data and images related to cardiovascular medicine. It gives medical professionals access to high-quality digital images in a centralized format from a variety of modalities, including angiography and echocardiography. This increases the efficiency of workflow across cardiology departments, improves diagnostic accuracy, and permits remote access.

Detailed technological data will be provided for all specified segments classified in this report.

Cardiovascular Information System Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for cardiovascular information system patents, having around 144,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with cardiovascular information system patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the cardiovascular information system field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Medtronic Inc.

An international leader in medical technology, the company was founded in 1949 and has its headquarters in Dublin, Ireland. It focuses on creating cutting-edge cardiovascular information systems and gadgets, such as sophisticated monitoring and diagnostic instruments. With the help of Medtronic's solutions, cardiovascular conditions will be better managed and treated globally, leading to better patient outcomes.

Koninklijke Philips NV

Based in Amsterdam, Netherlands, and established in 1891, Philips is a leader in health technology worldwide. ...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other companies include Genentech Inc., Cardiac Pacemakers Inc., Samsung Electronics Co Ltd, Massachusetts Inst Technology, Bristol Myers Squibb Co, Amgen Inc., Cardiac Pacemakers Inc., Millennium Pharm Inc., Broad Inst Inc., Resmed Pty LTD, Gen Hospital Corp, Cilag Gmbh Int, among others.

Reasons to Purchase this Report

The cardiovascular information system patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

  • Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of cardiovascular information systems.
  • Innovation Insights: The patent analysis reveals new innovations and technologies in cardiovascular information systems.
  • Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the cardiovascular information systems patent landscape.
  • Risk Assessment: In technology-intensive fields such as cardiovascular information systems, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Cardiovascular Information System Patent Landscape Report

  • Who are the key players in the cardiovascular information system patent landscape?
  • How is the patent portfolio distributed geographically?
  • What are the emerging trends in cardiovascular information system patents?
  • How has the patent landscape evolved over time?
  • What are the strategic insights for market players and investors?
  • What is the technological focus of patents in the cardiovascular information system industry?
  • How do patent strategies impact competitive advantage?
  • What are the implications of patent filings in cardiovascular information systems?
  • What are the challenges and opportunities in the cardiovascular information system patent landscape?
  • What are the regulatory and legal considerations?
  • What technological innovations have recently emerged in cardiovascular information systems?

Related Reports

Global Cardiovascular Information System Market

Global Cardiovascular Drugs Market

Global Cardiovascular Devices Market

Global Cardiovascular Stents Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Scope of the Report Details
Analysis by System Type
  • CVIS
  • Cardiology PACS
Analysis by Component
  • Software
  • Services
Analysis by Mode of Operation
  • Web-Based
  • Cloud Based
  • On-Site
Key Players Mentioned
  • Medtronic Inc
  • Koninklijke Philips Nv 
  • Genentech Inc
  • Cardiac Pacemakers Inc
  • Samsung Electronics Co Ltd
  • Massachusetts Inst Technology
  • Bristol Myers Squibb Co
  • Amgen Inc
  • Cardiac Pacemakers Inc
  • Millennium Pharm Inc
  • Broad Inst Inc
  • Resmed Pty LTD
  • Gen Hospital Corp
  • Cilag Gmbh Int
  • Others
Geographies Covered
  • North America
  • Europe
  • Asia Pacific
  • Others

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,299

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 4,899

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 5,899

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124